CELCUITY INC Share Price Today: Live Updates & Key Insights

CELCUITY INC share price today is $82.77, up -6.47%. The stock opened at $88.23 against the previous close of $88.34, with an intraday high of $88.23 and low of $82.24.

CELCUITY INC Share Price Chart

CELCUITY INC

us-stock
To Invest in {{usstockname}}
us-stock

CELCUITY INC Share Price Performance

$82.77 -0.0647(-6.47%) CELC at 27 Jul 2026 02:23 PM Biotechnology
Lowest Today 82.24
Highest Today 88.23
Today’s Open 88.23
Prev. Close 88.34
52 Week High 151.02
52 Week Low 34.30
Day’s Range: Low 82.24 High 88.23
52-Week Range: Low 34.30 High 151.02
1 day return -
1 Week return -6.36
1 month return -17.49
3 month return -34.22
6 month return -27.79
1 year return +124.02
3 year return +726.12
5 year return +301.99
10 year return -

CELCUITY INC Institutional Holdings

Baker Bros Advisors LP 16.23

venBio Select Advisor LLC 6.92

Perceptive Advisors LLC 6.41

RTW INVESTMENTS, LLC 6.23

BlackRock Inc 5.56

NEA Management Company, LLC 4.69

Vanguard Group Inc 4.67

Vanguard Capital Management, LLC 3.66

Deerfield Management Co 3.51

State Street Corp 3.11

Vanguard Total Stock Mkt Idx Inv 2.86

Morgan Stanley - Brokerage Accounts 2.76

Soleus Capital Management, L.P. 2.63

T. Rowe Price Associates, Inc. 2.62

State Street® SPDR® S&P® Biotech ETF 2.31

TANG CAPITAL MANAGEMENT LLC 2.15

iShares Russell 2000 ETF 2.04

Geode Capital Management, LLC 1.83

The Toronto-Dominion Bank 1.81

The Goldman Sachs Group Inc 1.57

Bank of America Corp 1.46

Apis Capital Advisors, LLC 1.06

Nearwater Capital Markets, Ltd 0.97

Vanguard Institutional Extnd Mkt Idx Tr 0.89

Fidelity Select Biotechnology 0.77

iShares Russell 2000 Growth ETF 0.73

Fidelity Small Cap Index 0.71

American Century Small Cap Growth Inv 0.70

American Century U.S. Small Cap Growth 0.70

Belfius Equities Cure C Cap 0.62

T. Rowe Price Integrated US SmCapGrEq 0.59

Artisan International Small-Mid Investor 0.59

Artisan Non-U.S. Small-Mid Growth Comp 0.59

T. Rowe Price New Horizons 0.55

US Small-Cap Growth II Equity Comp 0.50

Eventide Healthcare & Life Sciences I 0.50

Vanguard Russell 2000 ETF 0.45

Russell 2000 Equity Index Fund B 0.45

Russell 2000 Index Non-Lendable Fund 0.45

State St Russell Sm/Mid Cp® Indx SL Cl I 0.45

CELCUITY INC Market Status

Strong Buy: 5

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

CELCUITY INC Fundamentals

Market Cap 4308.01 M

PB Ratio 82.1078

PE Ratio 0.0

Enterprise Value 4243.66 M

Total Assets 466.56 M

Volume 1294446

CELCUITY INC Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-56511990 -56.5M, FY22:-41348989 -41.3M, FY21:-30564381 -30.6M, FY20:-9088704 -9.1M, FY19:-7020527 -7.0M

Quarterly Revenue Q1/2026:0 0.0M, Q3/2025:154000 0.2M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M

Quarterly Profit Q1/2026:-47000 -0.0M, Q3/2025:-41000 -0.0M, Q2/2025:-40000 -0.0M, Q1/2025:-37000 -0.0M, Q3/2024:null 0.0M

Quarterly Net worth Q1/2026:-52841000 -52.8M, Q3/2025:-43804000 -43.8M, Q2/2025:-45268000 -45.3M, Q1/2025:-36997000 -37.0M, Q3/2024:-29791789 -29.8M

About CELCUITY INC & investment objective

Company Information Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-) or HR+/HER2-, advanced or metastatic breast cancer (ABC), and patients with metastatic castration resistant prostate cancer (mCRPC). The company had a license agreement with Pfizer Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was incorporated in 2011 and is based in Minneapolis, Minnesota.

Organisation Biotechnology

Employees 155

Industry Biotechnology

CEO Mr. Brian F. Sullivan

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

CELCUITY INC FAQs

What is the share price of CELCUITY INC today?

The current share price of CELCUITY INC is $82.77.

Can I buy CELCUITY INC shares in India?

Yes, Indian investors can buy CELCUITY INC shares by opening an international trading and demat account with Motilal Oswal.

How to buy CELCUITY INC shares in India?

You can easily invest in CELCUITY INC shares from India by:

Can I buy fractional shares of CELCUITY INC?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of CELCUITY INC?

CELCUITY INC has a market cap of $4308.01 M.

In which sector does CELCUITY INC belong?

CELCUITY INC operates in the Biotechnology sector.

What documents are required to invest in CELCUITY INC stocks?

To invest, you typically need:

What is the PE and PB ratio of CELCUITY INC?

The PE ratio of CELCUITY INC is N/A and the PB ratio is 82.11.